For any queries, please contact Customer Services or your Account Manager. Dismiss
News & Analysis (6)
-
April 02, 2026 | Comment Semaglutide patent expiry exposes global split on access, exclusivity
..., with the Patent Trial and Appeal Board declining to review key patents in 2023.Critics, including I-MAK...
Sections: Intellectual Property
-
March 05, 2026 | Comment US GAO march-in rule analysis angers both sides of debate
...unnecessary limbo we have been in for over 40 years on this issue since the Bayh-Dole Act was passed,” said I-MAK...
Sections: Intellectual Property
-
December 03, 2025 | Insight IP stakeholders split on potential impact of US PTAB rulemaking
...challenge the patent thickets that delay competition and the freedom to access affordable medicines,” I-MAK...
Sections: Intellectual Property
Get the inside track, with MLex
With a global network of expert journalists digging deep into the areas of risk that matter to your business and clients—and the highest standards of impartiality—you can have complete trust in MLex to keep you ahead of the regulatory curve.
- Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
- Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
- Predictive analysis from specialists across North America, the UK and Europe, Latin America and Asia-Pacific
- Curated case files bringing together news, analysis and source documents in a single timeline
TRY MLEX FREE FOR 14 DAYS
Already a subscriber? Click here to login